Seattle Genetics Inc (NASDAQ:SGEN)

35.00
Delayed Data
As of May 05
 +0.80 / +2.34%
Today’s Change
30.05
Today|||52-Week Range
44.95
+8.93%
Year-to-Date

Today’s Trading

Previous close34.20
Today’s open34.16
Day’s range33.89 - 35.10
Volume1,594,658
Average volume (3 months)1,147,490
Market cap$4.3B
Dividend yield--
Data as of 3:59pm ET, 05/05/2015

Growth & Valuation

Earnings growth (last year)-21.57%
Earnings growth (this year)-20.74%
Earnings growth (next 5 years)-28.70%
Revenue growth (last year)+6.50%
P/E ratioNM
Price/Sales13.83
Price/Book20.11

Competitors

 Today’s
change
Today’s
% change
GRFSGrifols SA-0.38-1.19%
HZNPHorizon Pharma PLC-0.87-2.93%
AKRXAkorn Inc-2.21-5.24%
RCPTReceptos Inc-7.36-4.80%
Data as of 3:59pm ET, 05/05/2015

Financials

Next reporting dateJuly 29, 2015
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$286.8M
Annual profit (last year)-$76.1M
Net profit margin-26.55%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
Chief Operating Officer
Eric L. Dobmeier
Corporate headquarters
Bothell, Washington

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers